PatientWing Insights
Expert perspectives, research updates, and innovative solutions driving the future of patient recruitment and clinical trials.
Single-channel recruitment misses most eligible patients. See how PatientWing combines digital ads, advocacy partnerships, community outreach, and multilingual support to reach patients where they are and keep them engaged.
July 1, 2026
Rare disease trials face extraordinary challenges. Imagine navigating uncharted waters with a small and dispersed patient population, each living with a disease that remains largely mysterious. It’s a daunting task—but one that can lead to incredible breakthroughs for patients and their families.
This article emphasizes the benefits of incorporating pre-screening and phone screening into the clinical study recruitment process to overcome logistical challenges and improve participant engagement. By filtering qualified participants early and building trust through personal interactions, these strategies streamline the first site visit and enhance overall recruitment success.
Rare disease patients often endure a prolonged journey to get an accurate diagnosis, facing multiple specialists, conflicting opinions, and significant personal challenges. Comprehensive resources and patient stories can provide valuable information and emotional support, helping patients and caregivers make informed decisions and foster a sense of community.
Clinical research drives medical advancements but faces significant challenges in recruiting participants, particularly from minority groups. At PatientWing, we are dedicated to overcoming these barriers and achieving true diversity in clinical trials through collaborative efforts from providers, sponsors, and participants.
Five patients that PatientWing enrolled showed significant improvements in/after the study with attention test after deep brain stimulation.
PatientWing is excited to attend the 20th BioPharma Clinical Trials Nexus Conference in San Diego, California May 8th – 9th.